Tevogen Bio Holdings Inc. (NASDAQ:TVGN) revealed plans to broaden the scope of its TVGN 489 experimental medication to ...

Qiagen (NYSE:QGEN) announced a new commercial collaboration and joint marketing agreement with French company ID Solutions to ...

For patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, 10-year data from the ...

As the number of space travelers is increasing through commercial missions, it becomes more important to understand how space ...

Gene editing, once a theoretical ambition, has matured into a revolutionary frontier in biotechnology. Technologies like CRISPR-Cas9, TALENs, and Zinc Finger Nucleases (ZFNs) have unlocked ...

The global sales of DNA diagnostics are estimated to be worth USD 27,094.2 million in 2024 and are anticipated to reach a value of USD 57,420.1 million by 2034. Sales are projected to rise at a CAGR ...

New price of $2,753 for the GraftAssureCore assay increases total addressable market size and margin opportunityBrings pricing in line with existing competitive technologyExpands market appeal for pro ...

Howl-elujah! You’ve probably heard that dogs can be trained to sniff out cancer. Now, Israeli startup SpotItEarly is ...

The increasing incidence of infectious and chronic illnesses is boosting the need for early and precise diagnosis, with AI playing a crucial role by ...

Future Market Insights’ updated report on the electronic medical record ecosystem highlights various opportunities and growth spots for the coming decade. As per the analysis, the electronic medical ...

Having someone else push you around rarely feels good. A new study on power and personality shows why this is particularly ...

Officials said eggs produced after the onset of illness did not enter the food supply, and there are no signs of illness in ...